Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Articles

Pfizer, Merck, Sanofi, and AstraZeneca are among the companies reporting revenue declines from generic-drug incursion. A look at what the companies are doing to stimulate growth.

Pfizer, Merck, Sanofi, and AstraZeneca Facing the Generic-Drug Squeeze

Melanie Sena is community editor of Pharmaceutical Technology.

A new study reveals how a promising anticancer specifically kills prostate cancer cells by compromising their ability to withstand environmental stress.

Researchers Uncover How a Potent Compound Kills Prostate Cancer Cells

Extensive comparability testing is required to ensure that biosimilars have comparable profiles to their reference products.

Demonstrating Biosimilarity

Antoinette Konski is a partner at Foley & Lardner, akonski@foley.com

The US Supreme Court's Myriad decision satisfied both patient groups and patent holders

New Gene Patent Rules

Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

Advances in techniques and single-use systems are revolutionizing vaccine manufacturing.

Bioprocessing Advances in Vaccine Manufacture

FDA releases FY 2014 generic-drug user fees.

FDA Publishes Generic-Drug User Fees

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

FDA funds research to further development of innovative generics, while working to address review and approval issues.

Generic Drugs Face Regulatory and Scientific Challenges

A new method of vaccine design, called the Multiple Antigen Presentation System (MAPS), may result in vaccines that bring together the benefits of whole-cell and acellular or defined subunit vaccination.

New Modular Vaccine Design Combines Existing Vaccine Technologies

Australian team develops method for making ultrafine particles for more efficient drug delivery.

New Manufacturing Method Improves Drug Delivery of Asthma Inhalers

Susan Schniepp, vice-president of quality and regulatory affairs at Allergy Laboratories and co-chair of the program planning committee for the 2013 PDA/FDA Joint Regulatory Conference, discusses quality systems and related considerations in parenteral drug manufacturing.